Invention Application
US20030232849A1 N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
失效
N-取代 - 杂芳氧基 - 芳氧基 - 嘧啶-2,4,6-三酮金属蛋白酶抑制剂
- Patent Title: N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
- Patent Title (中): N-取代 - 杂芳氧基 - 芳氧基 - 嘧啶-2,4,6-三酮金属蛋白酶抑制剂
-
Application No.: US10424382Application Date: 2003-04-28
-
Publication No.: US20030232849A1Publication Date: 2003-12-18
- Inventor: Mark C. Noe , Lilli Ann Wolf-Gouveia
- Applicant: Pfizer Inc.
- Applicant Address: null
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: null
- Main IPC: A61K031/515
- IPC: A61K031/515 ; C07D43/02
Abstract:
The present invention relates to N-substituted-heteroaryloxy-aryloxy-2,4,6-trione metalloproteinase inhibitors of the formula 1 wherein X, A, Y, B, G, and R1 are as defined in the specification, and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders.
Public/Granted literature
- US06919332B2 N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors Public/Granted day:2005-07-19
Information query
